Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Ruxolitinib
Latest prescription information about Ruxolitinib. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Ruxolitinib
Trade Name(s): International- Jakafi. Why it is prescribed (Indications) : This medication is a kinase inhibitor, prescribed for high-risk myelofibrosis. It blocks certain substances (JAK1 and JAK2) that are involved in myelofibrosis. When it is not to be taken (Contraindications): Contraindicated in patients with known hypersensitivity.
Dosage & When it is to be taken : PO- The starting dose is 20 mg 2 times per day, for patients with platelet count greater than 200 X 109/L. How it should be taken : It comes as a tablet to take by mouth, with or without food. Warnings and Precautions : * Caution should be exercised in patients with history of liver or kidney impairment, patients on dialysis, during pregnancy and breastfeeding. * It may cause dizziness, avoid performing any hazardous activity while taking this medication. * Patient may develop with certain types of infection; discuss with your healthcare provider before taking this medication. * It may reduce platelet counts; avoid injury or bruising. * Monitor complete blood count regularly while taking this medication. Side Effects : Most Frequent - Thrombocytopenia and anemia. Miscellaneous - Bruising, dizziness, headache, urinary tract infection, weight gain, flatulence, herpes zoster. * Avoid excess dosage. Storage Conditions : Store it at room temperature (20° to 25°C). |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Drugs Index
Pharma Links 
Recently added Drugs
Quick Links
Ask an Expert
